Literature DB >> 16603524

Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds.

Cybele C García1, Mahmoud Djavani2, Ivan Topisirovic3, Katherine L B Borden3, María S Salvato2, Elsa B Damonte1.   

Abstract

Several disulfide-based and azoic compounds have shown antiviral and virucidal properties against arenaviruses in virus yield-inhibition and inactivation assays, respectively. The most effective virucidal agent, the aromatic disulfide NSC20625, was able to inactivate two strains of the prototype arenavirus species Lymphocytic choriomeningitis virus (LCMV). Inactivated viral particles retained the biological functions of the virion envelope glycoproteins in virus binding and uptake, but were unable to perform viral RNA replication. Furthermore, in inactivated virions, the electrophoretic profile of the Z protein was altered when analysed under non-reducing conditions, whereas the patterns of the proteins NP and GP1 remained unaffected. Treatment of a recombinant LCMV Z protein with the virucidal agents induced unfolding and oligomerization of Z to high-molecular-mass aggregates, probably due to metal-ion ejection and the formation of intermolecular disulfide bonds through the cysteine residues of the Z RING finger. NSC20625 also exhibited antiviral properties in LCMV-infected cells without affecting other cellular RING-motif proteins, such as the promyelocytic leukaemia protein PML. Altogether, the investigations described here illustrate the potential of the Z protein as a promising target for therapy and the prospects of the Z-reactive compounds to prevent arenavirus dissemination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603524      PMCID: PMC2423342          DOI: 10.1099/vir.0.81667-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  65 in total

1.  Zinc-binding properties of Junín virus nucleocapsid protein.

Authors:  M Alejandra Tortorici; P Daniel Ghiringhelli; Mario E Lozano; César G Albariño; Víctor Romanowski
Journal:  J Gen Virol       Date:  2001-01       Impact factor: 3.891

Review 2.  Molecular phylogeny of the arenaviruses.

Authors:  J C S Clegg
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

3.  Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor.

Authors:  Robert Eichler; Oliver Lenz; Thomas Strecker; Markus Eickmann; Hans-Dieter Klenk; Wolfgang Garten
Journal:  EMBO Rep       Date:  2003-10-10       Impact factor: 8.807

4.  Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis.

Authors:  Benjamin W Neuman; Brian D Adair; John W Burns; Ronald A Milligan; Michael J Buchmeier; Mark Yeager
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain.

Authors:  P S Brzovic; J Meza; M C King; R E Klevit
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

6.  Myristic acid analogs are inhibitors of Junin virus replication.

Authors:  S M Cordo; N A Candurra; E B Damonte
Journal:  Microbes Infect       Date:  1999-07       Impact factor: 2.700

7.  Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds.

Authors:  C C García; N A Candurra; E B Damonte
Journal:  Antivir Chem Chemother       Date:  2000-05

8.  Spectroscopic characterization of Co(II)-, Ni(II)-, and Cd(II)-substituted wild-type and non-native retroviral-type zinc finger peptides.

Authors:  X Chen; M Chu; D P Giedroc
Journal:  J Biol Inorg Chem       Date:  2000-02       Impact factor: 3.358

9.  Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.

Authors:  W G Rice; J A Turpin; C A Schaeffer; L Graham; D Clanton; R W Buckheit; D Zaharevitz; M F Summers; A Wallqvist; D G Covell
Journal:  J Med Chem       Date:  1996-09-13       Impact factor: 7.446

10.  Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP).

Authors:  Robert Eichler; Thomas Strecker; Larissa Kolesnikova; Jan ter Meulen; Winfried Weissenhorn; Stephan Becker; Hans Dieter Klenk; Wolfgang Garten; Oliver Lenz
Journal:  Virus Res       Date:  2004-03-15       Impact factor: 3.303

View more
  18 in total

Review 1.  Novel approaches in anti-arenaviral drug development.

Authors:  Andrew M Lee; Antonella Pasquato; Stefan Kunz
Journal:  Virology       Date:  2010-12-22       Impact factor: 3.616

2.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

3.  Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses.

Authors:  Ziying Han; Jianhong Lu; Yuliang Liu; Benjamin Davis; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Matthias J Schnell; Jay E Wrobel; Allen B Reitz; Ronald N Harty
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

Review 4.  Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.

Authors:  Sheli R Radoshitzky; Jens H Kuhn; Fabian de Kok-Mercado; Peter B Jahrling; Sina Bavari
Journal:  Expert Opin Drug Discov       Date:  2012-05-19       Impact factor: 6.098

Review 5.  Progress in the experimental therapy of severe arenaviral infections.

Authors:  Brian B Gowen; Mike Bray
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

Review 6.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

7.  An antiviral disulfide compound blocks interaction between arenavirus Z protein and cellular promyelocytic leukemia protein.

Authors:  C C García; I Topisirovic; M Djavani; K L B Borden; E B Damonte; M S Salvato
Journal:  Biochem Biophys Res Commun       Date:  2010-02-10       Impact factor: 3.575

8.  A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress.

Authors:  Jianhong Lu; Ziying Han; Yuliang Liu; Wenbo Liu; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 9.  Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.

Authors:  Lisa McLay; Aftab Ansari; Yuying Liang; Hinh Ly
Journal:  Antiviral Res       Date:  2012-12-20       Impact factor: 5.970

Review 10.  Multifunctional nature of the arenavirus RING finger protein Z.

Authors:  Sarah Katharina Fehling; Frank Lennartz; Thomas Strecker
Journal:  Viruses       Date:  2012-11-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.